Development and Validation of a Machine Learning Model for the Prediction of Bloodstream Infections in Patients with Hematological Malignancies and Febrile Neutropenia
Antibiotics · 28.12.2024 · 14 (1) · 13
DOI: 10.3390/antibiotics14010013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 28.12.2024. Verfasst von Antonio Gallardo-Pizarro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, 08036 Barcelona, Spain. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, AGAUR (Agencia de Gestión de Ayudas Universitarias y de Investigación) of Catalunya, European Regional Development Fund (EDRD).
Abstract (Originalsprache)
Background/Objectives: The rise of multidrug-resistant (MDR) infections demands personalized antibiotic strategies for febrile neutropenia (FN) in hematological malignancies. This study investigates machine learning (ML) for identifying patient profiles with increased susceptibility to bloodstream infections (BSI) during FN onset, aiming to tailor treatment approaches.
Methods
From January 2020 to June 2022, we used the unsupervised ML algorithm KAMILA to analyze data from hospitalized hematological malignancy patients. Eleven features categorized clinical phenotypes and determined BSI and multidrug-resistant Gram-negative bacilli (MDR-GNB) prevalences at FN onset. Model performance was evaluated with a validation cohort from July 2022 to March 2023.
Results
Among 462 FN episodes analyzed in the development cohort, 116 (25.1%) had BSIs. KAMILA’s stratification identified three risk clusters: Cluster 1 (low risk), Cluster 2 (intermediate risk), and Cluster 3 (high risk). Cluster 2 (28.4% of episodes) and Cluster 3 (43.7%) exhibited higher BSI rates of 26.7% and 37.6% and GNB BSI rates of 13.4% and 19.3%, respectively. Cluster 3 had a higher incidence of MDR-GNB BSIs, accounting for 75% of all MDR-GNB BSIs. Cluster 1 (27.9% of episodes) showed a lower BSI risk (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, 08036 Barcelona, Spain.
- Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036 Barcelona, Spain.
- Emergency Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, 75010 Paris, France.
- Institut Pierre Louis d'Épidémiologie et de Santé Publique, Institut National de la Santé et de la Recherche Médicale (INSERM), Sorbonne University, 75012 Paris, France.
- Department of Microbiology, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
- Department of Hematology, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
ORCID-Profile: Antonio Gallardo-Pizarro, Tommaso Francesco Aiello, Olivier Peyrony, Alex Soriano
Förderung
- Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III
- AGAUR (Agencia de Gestión de Ayudas Universitarias y de Investigación) of Catalunya
- European Regional Development Fund (EDRD)
- Instituto de Salud Carlos III (ISCIII)
- La Ligue Nationale contre le Cancer
- La Direction de l’Assistance Publique—Hôpitaux de Paris (APHP)
- Collège de Maladies Infectieuses et Tropicales, France
- Collège des Universitaires de Maladies Infectieuses et Tropicales
Zitieren
APA
Gallardo-Pizarro, A., Teijón-Lumbreras, C., Monzo-Gallo, P., Aiello, T. F., Chumbita, M., Peyrony, O., Gras, E., Pitart, C., Mensa, J., Esteve, J., Soriano, A., & Garcia-Vidal, C. (2024). Development and Validation of a Machine Learning Model for the Prediction of Bloodstream Infections in Patients with Hematological Malignancies and Febrile Neutropenia. Antibiotics, 14(1), 13. https://doi.org/10.3390/antibiotics14010013
Vancouver
Gallardo-Pizarro A, Teijón-Lumbreras C, Monzo-Gallo P, Aiello TF, Chumbita M, Peyrony O, et al. Development and Validation of a Machine Learning Model for the Prediction of Bloodstream Infections in Patients with Hematological Malignancies and Febrile Neutropenia. Antibiotics. 2024;14(1):13. doi:10.3390/antibiotics14010013
BibTeX
@article{GallardoPizarro2024,
author = {Gallardo-Pizarro, Antonio and Teijón-Lumbreras, Christian and Monzo-Gallo, Patricia and Aiello, Tommaso Francesco and Chumbita, Mariana and Peyrony, Olivier and Gras, Emmanuelle and Pitart, Cristina and Mensa, Josep and Esteve, Jordi and Soriano, Alex and Garcia-Vidal, Carolina},
title = {Development and Validation of a Machine Learning Model for the Prediction of Bloodstream Infections in Patients with Hematological Malignancies and Febrile Neutropenia},
journal = {Antibiotics},
year = {2024},
volume = {14},
number = {1},
pages = {13},
doi = {10.3390/antibiotics14010013}
}
EUVIMED